Patents by Inventor Wayne Volkmuth
Wayne Volkmuth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230167169Abstract: The present disclosure provides anti-circumsporozoite (CSP) antibodies, compositions comprising such antibodies. Also disclosed are methods of producing the disclosed antibodies and methods of treating or preventing malaria using the same.Type: ApplicationFiled: January 26, 2023Publication date: June 1, 2023Applicant: Atreca, Inc.Inventors: Daniel Eric Emerling, Randal R. Ketchem, Shaun M. Lippow, Wayne Volkmuth, Katherine L. Williams
-
Patent number: 11655290Abstract: The present disclosure provides anti-circumsporozoite (CSP) antibodies, compositions comprising such antibodies. Also disclosed are methods of producing the disclosed antibodies and methods of treating or preventing malaria using the same.Type: GrantFiled: June 16, 2022Date of Patent: May 23, 2023Assignee: Atreca, Inc.Inventors: Daniel Eric Emerling, Randal R. Ketchem, Shaun M. Lippow, Wayne Volkmuth, Katherine L. Williams
-
Publication number: 20230140035Abstract: Provided herein are antibodies that bind to tumor tissue through a binding interaction with an extracellular RNA-protein complex. Such antibodies are used in methods of inducing an immune response and methods of inhibiting tumor cell growth. Additionally provided are methods of producing such antibodies.Type: ApplicationFiled: September 26, 2022Publication date: May 4, 2023Inventors: Jeff DeFalco, Daniel Eric Emerling, Jessica Finn, Norman Michael Greenberg, Vera Huang, Shaun M. Lippow, Fengling Liu, Amy Manning-Bog, William H. Robinson, Alexander Scholz, Tito Serafini, Nikhil Vad, Wayne Volkmuth, Yann Chong TAN
-
Publication number: 20230002483Abstract: The present disclosure provides anti-circumsporozoite (CSP) antibodies, compositions comprising such antibodies. Also disclosed are methods of producing the disclosed antibodies and methods of treating or preventing malaria using the same.Type: ApplicationFiled: June 16, 2022Publication date: January 5, 2023Applicant: Atreca, Inc.Inventors: Daniel Eric Emerling, Randal R. Ketchem, Shaun M. Lippow, Wayne Volkmuth, Katherine L. Williams
-
Patent number: 11472885Abstract: Provided herein are antibodies that bind to tumor tissue through a binding interaction with an extracellular RNA-protein complex. Such antibodies are used in methods of inducing an immune response and methods of inhibiting tumor cell growth. Additionally provided are methods of producing such antibodies.Type: GrantFiled: February 14, 2020Date of Patent: October 18, 2022Assignee: Atreca, Inc.Inventors: Jeff DeFalco, Daniel Eric Emerling, Jessica Finn, Norman Michael Greenberg, Vera Huang, Shaun M. Lippow, Fengling Liu, Amy Manning-Bog, William H. Robinson, Alexander Scholz, Tito Serafini, Yann Chong Tan, Nikhil Vad, Wayne Volkmuth
-
Publication number: 20220155319Abstract: Disclosed herein are methods and compositions for using nanoexpression to interrogate antigen specificity within antibody repertoires. Also disclosed herein is an antibody display system composition comprising one or more recombinant nucleic acid sequences comprising a first nucleic acid sequence encoding a heavy chain variable region sequence or fragment thereof operatively linked to a first identification region sequence and a second nucleic acid sequence encoding a light chain variable region sequence or fragment thereof operatively linked to a second identification region sequence.Type: ApplicationFiled: January 31, 2022Publication date: May 19, 2022Inventors: Jeff DeFALCO, Daniel EMERLING, Shaun LIPPOW, Sean CARROLL, Wayne VOLKMUTH, Norm GREENBERG, Tito SERAFINI
-
Publication number: 20200355698Abstract: Disclosed herein are methods and compositions for using nanoexpression to interrogate antigen specificity within antibody repertoires. Also disclosed herein is an antibody display system composition comprising one or more recombinant nucleic acid sequences comprising a first nucleic acid sequence encoding a heavy chain variable region sequence or fragment thereof operatively linked to a first identification region sequence and a second nucleic acid sequence encoding a light chain variable region sequence or fragment thereof operatively linked to a second identification region sequence.Type: ApplicationFiled: April 9, 2020Publication date: November 12, 2020Inventors: Jeff DeFalco, Daniel Emerling, Shaun Lippow, Sean Carroll, Wayne Volkmuth, Norm Greenberg, Tito Serafini
-
Publication number: 20200325242Abstract: Provided herein are antibodies that bind to tumor tissue through a binding interaction with an extracellular RNA-protein complex. Such antibodies are used in methods of inducing an immune response and methods of inhibiting tumor cell growth. Additionally provided are methods of producing such antibodies.Type: ApplicationFiled: February 14, 2020Publication date: October 15, 2020Inventors: Jeff DeFalco, Daniel Eric Emerling, Jessica Finn, Norman Michael Greenberg, Vera Huang, Shaun M. Lippow, Fengling Liu, Amy Manning-Bog, William H. Robinson, Alexander Scholz, Tito Serafini, Yann Chong Tan, Nikhil Vad, Wayne Volkmuth
-
Patent number: 10620219Abstract: Disclosed herein are methods and compositions for using nanoexpression to interrogate antigen specificity within antibody repertoires. Also disclosed herein is an antibody display system composition comprising one or more recombinant nucleic acid sequences comprising a first nucleic acid sequence encoding a heavy chain variable region sequence or fragment thereof operatively linked to a first identification region sequence and a second nucleic acid sequence encoding a light chain variable region sequence or fragment thereof operatively linked to a second identification region sequence.Type: GrantFiled: December 13, 2017Date of Patent: April 14, 2020Assignee: ATRECA, INC.Inventors: Jeff DeFalco, Daniel Emerling, Shaun Lippow, Sean Carroll, Wayne Volkmuth, Norm Greenberg, Tito Serafini
-
Patent number: 10329575Abstract: The present invention provides DNA molecules as shown in SEQ ID NO:2199 that constitute fragments of the genome of a plant. The DNA molecules are useful for specifying a gene product in cells as regulatory sequences. One of ordinary skill in the art, having this data, can obtain cloned DNA fragments, synthetic DNA fragments or polypeptides constituting desired sequences by recombinant methodology known in the art or described therein.Type: GrantFiled: May 11, 2015Date of Patent: June 25, 2019Assignee: CERES, INC.Inventors: Nickolai Alexandrov, Shing Kwok, Peter Mascia, Jack Okamuro, Roger Pennell, Richard Schneeberger, Tatiana Tatarinova, Wayne Volkmuth, Nestor Apuya, Vyacheslav Brover, Jean-Baptiste Dumas, Yiwen Fang, Kenneth A. Feldmann, Diane K. Jofuku, Edward A. Kiegle, Bill Kimmerly
-
Publication number: 20190184007Abstract: The invention provides influenza vaccines and methods which improve the safety of influenza vaccines further, in particular in relation to the risk of causing narcolepsy in adjuvanted vaccines.Type: ApplicationFiled: March 6, 2019Publication date: June 20, 2019Inventors: Syed Sohail AHMED, Lawrence Steinman, Wayne Volkmuth
-
Publication number: 20180100864Abstract: Disclosed herein are methods and compositions for using nanoexpression to interrogate antigen specificity within antibody repertoires. Also disclosed herein is an antibody display system composition comprising one or more recombinant nucleic acid sequences comprising a first nucleic acid sequence encoding a heavy chain variable region sequence or fragment thereof operatively linked to a first identification region sequence and a second nucleic acid sequence encoding a light chain variable region sequence or fragment thereof operatively linked to a second identification region sequence.Type: ApplicationFiled: December 13, 2017Publication date: April 12, 2018Inventors: Jeff DeFALCO, Daniel EMERLING, Shaun LIPPOW, Sean CARROLL, Wayne VOLKMUTH, Norm GREENBERG, Tito SERAFINI
-
Patent number: 9834766Abstract: The present disclosure provides methods for optimizing barcode design for multiplex DNA sequencing. Also disclosed are DNA barcodes optimized for use with particular sequencing technologies.Type: GrantFiled: September 4, 2012Date of Patent: December 5, 2017Assignee: Atreca, Inc.Inventors: Wayne Volkmuth, Yann Chong Tan
-
Publication number: 20170216425Abstract: The invention provides influenza vaccines and methods which improve the safety of influenza vaccines further, in particular in relation to the risk of causing narcolepsy in adjuvanted vaccines.Type: ApplicationFiled: October 4, 2016Publication date: August 3, 2017Inventors: Syed Sohail Ahmed, Lawrence Steinman, Wayne Volkmuth
-
Publication number: 20160076046Abstract: The present invention provides DNA molecules that constitute fragments of the genome of a plant, and polypeptides encoded thereby. The DNA molecules are useful for specifying a gene product in cells, either as a promoter or as a protein coding sequence or as an UTR or as a 3? termination sequence, and are also useful in controlling the behavior of a gene in the chromosome, in controlling the expression of a gene or as tools for genetic mapping, recognizing or isolating identical or related DNA fragments, or identification of a particular individual organism, or for clustering of a group of organisms with a common trait. One of ordinary skill in the art, having this data, can obtain cloned DNA fragments, synthetic DNA fragments or polypeptides constituting desired sequences by recombinant methodology known in the art or described herein.Type: ApplicationFiled: May 11, 2015Publication date: March 17, 2016Applicant: CERES, INC.Inventors: Nickolai ALEXANDROV, Nestor APUYA, Vyacheslav BROVER, Jean-Baptiste DUMAS, Yiwen FANG, Kenneth A. FELDMAN, Diane K. JOFUKU, Edward A. KIEGLE, Bill KIMMERLY, Shing KWOK, Peter Mascia, Jack OKAMURO, Roger PENNELL, Richard SCHNEEBERGER, Tatiana TATARINOVA, Wayne VOLKMUTH
-
Patent number: 9029523Abstract: The present invention provides DNA molecules that constitute fragments of the genome of a plant, and polypeptides encoded thereby. The DNA molecules are useful for specifying a gene product in cells, either as a promoter or as a protein coding sequence or as an UTR or as a 3? termination sequence, and are also useful in controlling the behavior of a gene in the chromosome, in controlling the expression of a gene or as tools for genetic mapping, recognizing or isolating identical or related DNA fragments, or identification of a particular individual organism, or for clustering of a group of organisms with a common trait. One of ordinary skill in the art, having this data, can obtain cloned DNA fragments, synthetic DNA fragments or polypeptides constituting desired sequences by recombinant methodology known in the art or described herein.Type: GrantFiled: December 3, 2004Date of Patent: May 12, 2015Assignee: Ceres, Inc.Inventors: Nickolai Alexandrov, Nestor Apuya, Vyacheslav Brover, Jean-Baptiste Dumas, Yiwen Fang, Ken Feldmann, Diane Jofuku, Edward A. Kiegle, Bill Kimmerly, Shing Kwok, Peter Mascia, Jack Okamuro, Roger Pennell, Richard Schneeberger, Tatiana Tatarinova, Wayne Volkmuth
-
Publication number: 20150080266Abstract: The present disclosure provides methods for optimizing barcode design for multiplex DNA sequencing. Also disclosed are DNA barcodes optimized for use with particular sequencing technologies.Type: ApplicationFiled: September 4, 2012Publication date: March 19, 2015Applicant: Atreca, Inc.Inventors: Wayne Volkmuth, Yann Chong Tan
-
Publication number: 20150033417Abstract: The present invention provides DNA molecules that constitute fragments of the genome of a plant, and polypeptides encoded thereby. The DNA molecules are useful for specifying a gene product in cells, either as a promoter or as a protein coding sequence or as an UTR or as a 3? termination sequence, and are also useful in controlling the behavior of a gene in the chromosome, in controlling the expression of a gene or as tools for genetic mapping, recognizing or isolating identical or related DNA fragments, or identification of a particular individual organism, or for clustering of a group of organisms with a common trait. One of ordinary skill in the art, having this data, can obtain cloned DNA fragments, synthetic DNA fragments or polypeptides constituting desired sequences by recombinant methodology known in the art or described herein.Type: ApplicationFiled: December 3, 2004Publication date: January 29, 2015Inventors: Nickolai Alexandrov, Nestor Apuya, Vyacheslav Brover, Jean-Baptiste Dumas, Yiwen Fang, Ken Feldmann, Diane Jofuku, Edward A. Kiegle, Bill Kimmerly, Shing Kwok, Peter Mascia, Jack Okamuro, Roger Pennell, Richard Schneeberger, Tatiana Tatarinova, Wayne Volkmuth
-
Publication number: 20150011405Abstract: Disclosed herein are methods and compositions for using nanoexpression to interrogate antigen specificity within antibody repertoires. Also disclosed herein is an antibody display system composition comprising one or more recombinant nucleic acid sequences comprising a first nucleic acid sequence encoding a heavy chain variable region sequence or fragment thereof operatively linked to a first identification region sequence and a second nucleic acid sequence encoding a light chain variable region sequence or fragment thereof operatively linked to a second identification region sequence.Type: ApplicationFiled: June 30, 2014Publication date: January 8, 2015Inventors: Jeff DeFalco, Tito Serafini, Wayne Volkmuth
-
Publication number: 20140335116Abstract: The invention provides influenza vaccines and methods which improve the safety of influenza vaccines further, in particular in relation to the risk of causing narcolepsy in adjuvanted vaccines.Type: ApplicationFiled: May 12, 2014Publication date: November 13, 2014Applicant: NOVARTIS AGInventors: Syed Sohail Ahmed, Lawrence Steinman, Wayne Volkmuth